10-Q Filing

GUARDANT HEALTH, INC. CIK: 1576280 Q2 2019

Filing Information

Form Type	10-Q
Accession Number	`0001628280-19-010189`
Period End Date	20190630
Filing Date	20190807
Fiscal Year	2019
Fiscal Period	Q2
XBRL Instance	gh-20190630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 83 Income Statement 82 Cash Flow Statement 88 Stockholders Equity 44 Comprehensive Income 32

Balance Sheet 83 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$174.65M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$140.54M	USD	Point-in-time
Common stock, shares outstanding (shares)	`CommonStockSharesOutstanding`	85.83M	shares	Point-in-time
Common stock, shares outstanding (shares)	`CommonStockSharesOutstanding`	92.81M	shares	Point-in-time
Short-term marketable securities	`MarketableSecuritiesCurrent`	$370.97M	USD	Point-in-time
Common stock, shares issued (shares)	`CommonStockSharesIssued`	92.81M	shares	Point-in-time
Short-term marketable securities	`MarketableSecuritiesCurrent`	$278.42M	USD	Point-in-time
Common stock, shares issued (shares)	`CommonStockSharesIssued`	85.83M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$40.36M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$35.69M	USD	Point-in-time
Variable interest entity, assets	`VariableInterestEntityConsolidatedCarryingAmountAssets`	$45.10M	USD	Point-in-time
Variable interest entity, assets	`VariableInterestEntityConsolidatedCarryingAmountAssets`	$48.30M	USD	Point-in-time
Inventory	`InventoryNet`	$9.14M	USD	Point-in-time
Variable interest entity, liabilities	`VariableInterestEntityConsolidatedCarryingAmountLiabilities`	$1.20M	USD	Point-in-time
Inventory	`InventoryNet`	$14.18M	USD	Point-in-time
Variable interest entity, liabilities	`VariableInterestEntityConsolidatedCarryingAmountLiabilities`	$984.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.20M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.08M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$604.25M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$468.99M	USD	Point-in-time
Long-term marketable securities	`MarketableSecuritiesNoncurrent`	$77.56M	USD	Point-in-time
Long-term marketable securities	`MarketableSecuritiesNoncurrent`	$277.30M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$31.00M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$34.81M	USD	Point-in-time
Intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$8.99M	USD	Point-in-time
Intangible assets	`IntangibleAssetsNetExcludingGoodwill`	-	USD	Point-in-time
Goodwill	`Goodwill`	-	USD	Point-in-time
Capitalized license fees	`FiniteLivedIntangibleAssetsNet`	$7.80M	USD	Point-in-time
Capitalized license fees	`FiniteLivedIntangibleAssetsNet`	$7.31M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$1.24M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	-	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$2.05M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$3.16M	USD	Point-in-time
Total Assets	`Assets`	$587.40M	USD	Point-in-time
Total Assets	`Assets`	$939.99M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$15.70M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$10.64M	USD	Point-in-time
Accrued compensation	`DeferredCompensationLiabilityCurrent`	$12.99M	USD	Point-in-time
Accrued compensation	`DeferredCompensationLiabilityCurrent`	$13.69M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$7.08M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$11.09M	USD	Point-in-time
Capital lease, current	`CapitalLeaseObligationsCurrent`	$74.00K	USD	Point-in-time
Capital lease, current	`CapitalLeaseObligationsCurrent`	$97.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$16.14M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$16.50M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$46.94M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$57.05M	USD	Point-in-time
Capital lease, net of current portion	`CapitalLeaseObligationsNoncurrent`	$119.00K	USD	Point-in-time
Capital lease, net of current portion	`CapitalLeaseObligationsNoncurrent`	$80.00K	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$10.91M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$7.84M	USD	Point-in-time
Obligation related to royalty	`AccruedRoyaltiesNoncurrent`	$7.14M	USD	Point-in-time
Obligation related to royalty	`AccruedRoyaltiesNoncurrent`	$7.34M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	-	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$1.24M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$1.30M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$206.00K	USD	Point-in-time
Total Liabilities	`Liabilities`	$62.45M	USD	Point-in-time
Total Liabilities	`Liabilities`	$77.72M	USD	Point-in-time
Commitments and contingencies (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Redeemable noncontrolling interest	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$46.80M	USD	Point-in-time
Redeemable noncontrolling interest	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$41.80M	USD	Point-in-time
Common stock, par value of $0.00001 per share; 350,000,000 shares authorized as of June 30, 2019 and December 31, 2018; 92,806,252 and 85,832,454 shares issued and outstanding as of June 30, 2019 and December 31, 2018, respectively	`CommonStockValueOutstanding`	$1.00K	USD	Point-in-time
Common stock, par value of $0.00001 per share; 350,000,000 shares authorized as of June 30, 2019 and December 31, 2018; 92,806,252 and 85,832,454 shares issued and outstanding as of June 30, 2019 and December 31, 2018, respectively	`CommonStockValueOutstanding`	$1.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$764.03M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.13B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-83.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.34M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-314.81M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-280.80M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$483.15M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$296.85M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$308.61M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$468.13M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$276.78M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$815.47M	USD	Point-in-time
Total Liabilities, Redeemable Noncontrolling Interest and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$587.40M	USD	Point-in-time
Total Liabilities, Redeemable Noncontrolling Interest and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$939.99M	USD	Point-in-time

Income Statement 82 line items

Line Item	Tag	Value	Unit	Period
Precision oncology testing	`RevenuefromPrecisionOncologyTesting`	$32.01M	USD	2 Qtrs
Precision oncology testing	`RevenuefromPrecisionOncologyTesting`	$42.06M	USD	1 Quarter
Precision oncology testing	`RevenuefromPrecisionOncologyTesting`	$70.90M	USD	2 Qtrs
Precision oncology testing	`RevenuefromPrecisionOncologyTesting`	$17.82M	USD	1 Quarter
Development services	`RevenuefromDevelopmentServices`	$4.06M	USD	2 Qtrs
Development services	`RevenuefromDevelopmentServices`	$19.73M	USD	2 Qtrs
Development services	`RevenuefromDevelopmentServices`	$11.91M	USD	1 Quarter
Development services	`RevenuefromDevelopmentServices`	$1.56M	USD	1 Quarter
Total revenue	`Revenues`	$90.63M	USD	2 Qtrs
Total revenue	`Revenues`	$53.98M	USD	1 Quarter
Total revenue	`Revenues`	$19.38M	USD	1 Quarter
Total revenue	`Revenues`	$36.07M	USD	2 Qtrs
Cost of precision oncology testing	`CostsofPrecisionOncologyTesting`	$17.55M	USD	2 Qtrs
Cost of precision oncology testing	`CostsofPrecisionOncologyTesting`	$14.65M	USD	1 Quarter
Cost of precision oncology testing	`CostsofPrecisionOncologyTesting`	$9.51M	USD	1 Quarter
Cost of precision oncology testing	`CostsofPrecisionOncologyTesting`	$25.67M	USD	2 Qtrs
Cost of development services	`CostofDevelopmentServices`	$4.70M	USD	2 Qtrs
Cost of development services	`CostofDevelopmentServices`	$1.66M	USD	2 Qtrs
Cost of development services	`CostofDevelopmentServices`	$453.00K	USD	1 Quarter
Cost of development services	`CostofDevelopmentServices`	$2.18M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$19.53M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$11.55M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$19.81M	USD	2 Qtrs
Research and development expense	`ResearchAndDevelopmentExpense`	$35.85M	USD	2 Qtrs
Sales and marketing expense	`SellingAndMarketingExpense`	$22.89M	USD	2 Qtrs
Sales and marketing expense	`SellingAndMarketingExpense`	$37.25M	USD	2 Qtrs
Sales and marketing expense	`SellingAndMarketingExpense`	$11.57M	USD	1 Quarter
Sales and marketing expense	`SellingAndMarketingExpense`	$19.44M	USD	1 Quarter
General and administrative expense	`GeneralAndAdministrativeExpense`	$9.00M	USD	1 Quarter
General and administrative expense	`GeneralAndAdministrativeExpense`	$26.10M	USD	2 Qtrs
General and administrative expense	`GeneralAndAdministrativeExpense`	$15.52M	USD	2 Qtrs
General and administrative expense	`GeneralAndAdministrativeExpense`	$13.44M	USD	1 Quarter
Total costs and operating expenses	`CostsAndExpenses`	$77.42M	USD	2 Qtrs
Total costs and operating expenses	`CostsAndExpenses`	$69.24M	USD	1 Quarter
Total costs and operating expenses	`CostsAndExpenses`	$129.56M	USD	2 Qtrs
Total costs and operating expenses	`CostsAndExpenses`	$42.09M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-41.35M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-15.27M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-38.93M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-22.70M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.97M	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$5.58M	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$989.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$3.10M	USD	1 Quarter
Interest expense	`InterestExpense`	$580.00K	USD	2 Qtrs
Interest expense	`InterestExpense`	$287.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$648.00K	USD	2 Qtrs
Interest expense	`InterestExpense`	$317.00K	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$395.00K	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$4.54M	USD	2 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$96.00K	USD	2 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-51.00K	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-12.51M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-35.48M	USD	2 Qtrs
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-21.64M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-33.83M	USD	2 Qtrs
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$3.00K	USD	2 Qtrs
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$3.00K	USD	1 Quarter
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$-1.21M	USD	1 Quarter
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$-1.18M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-11.30M	USD	1 Quarter
Net loss	`ProfitLoss`	$-13.84M	USD	1 Quarter
Net loss	`ProfitLoss`	$-35.48M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-21.35M	USD	1 Quarter
Net loss	`ProfitLoss`	$-21.64M	USD	1 Quarter
Net loss	`ProfitLoss`	$-32.65M	USD	2 Qtrs
Fair value adjustment of redeemable noncontrolling interest	`NetIncomeLossAttributableToRedeemableNoncontrollingInterest`	-	USD	2 Qtrs
Fair value adjustment of redeemable noncontrolling interest	`NetIncomeLossAttributableToRedeemableNoncontrollingInterest`	$5.00M	USD	2 Qtrs
Fair value adjustment of redeemable noncontrolling interest	`NetIncomeLossAttributableToRedeemableNoncontrollingInterest`	-	USD	1 Quarter
Fair value adjustment of redeemable noncontrolling interest	`NetIncomeLossAttributableToRedeemableNoncontrollingInterest`	$300.00K	USD	1 Quarter
Net loss attributable to Guardant Health, Inc. common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-21.64M	USD	1 Quarter
Net loss attributable to Guardant Health, Inc. common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-37.65M	USD	2 Qtrs
Net loss attributable to Guardant Health, Inc. common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-35.48M	USD	2 Qtrs
Net loss attributable to Guardant Health, Inc. common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-11.60M	USD	1 Quarter
Net loss per share attributable to common stockholders, basic and diluted (in usd per share)	`EarningsPerShareBasicAndDiluted`	$-1.75	USD	1 Quarter
Net loss per share attributable to common stockholders, basic and diluted (in usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.43	USD	2 Qtrs
Net loss per share attributable to common stockholders, basic and diluted (in usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.13	USD	1 Quarter
Net loss per share attributable to common stockholders, basic and diluted (in usd per share)	`EarningsPerShareBasicAndDiluted`	$-2.92	USD	2 Qtrs
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	12.15M	shares	2 Qtrs
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.04M	shares	1 Quarter
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	12.39M	shares	1 Quarter
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	87.49M	shares	2 Qtrs

Cash Flow Statement 88 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-11.30M	USD	1 Quarter
Net loss	`ProfitLoss`	$-13.84M	USD	1 Quarter
Net loss	`ProfitLoss`	$-35.48M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-21.35M	USD	1 Quarter
Net loss	`ProfitLoss`	$-21.64M	USD	1 Quarter
Net loss	`ProfitLoss`	$-32.65M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$5.01M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.96M	USD	2 Qtrs
Unrealized translation gains on obligation related to royalty	`UnrealizedTranslationsGainLossOnObligationRelatedToRoyalty`	$205.00K	USD	2 Qtrs
Unrealized translation gains on obligation related to royalty	`UnrealizedTranslationsGainLossOnObligationRelatedToRoyalty`	$51.00K	USD	2 Qtrs
Non-cash stock-based compensation	`ShareBasedCompensation`	$2.46M	USD	2 Qtrs
Non-cash stock-based compensation	`ShareBasedCompensation`	$6.40M	USD	2 Qtrs
Non-cash interest expense	`NoncashInterestExpensePaid`	-	USD	2 Qtrs
Non-cash interest expense	`NoncashInterestExpensePaid`	$7.00K	USD	2 Qtrs
Amortization of discounts on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$1.28M	USD	2 Qtrs
Amortization of discounts on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-150.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-2.22M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-234.00K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$5.04M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-559.00K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.12M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.50M	USD	2 Qtrs
Deferred tax assets	`IncreaseDecreaseInDeferredIncomeTaxes`	-	USD	2 Qtrs
Deferred tax assets	`IncreaseDecreaseInDeferredIncomeTaxes`	$1.24M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-255.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$1.13M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$3.41M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$823.00K	USD	2 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$701.00K	USD	2 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$51.00K	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$2.94M	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$2.48M	USD	2 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$-3.07M	USD	2 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$-866.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$358.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$760.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-18.14M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-23.60M	USD	2 Qtrs
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$418.84M	USD	2 Qtrs
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$44.07M	USD	2 Qtrs
Maturity of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$75.62M	USD	2 Qtrs
Maturity of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$129.16M	USD	2 Qtrs
Business acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$9.77M	USD	2 Qtrs
Business acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$11.36M	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$5.75M	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-305.20M	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$20.20M	USD	2 Qtrs
Payments made on royalty obligations	`PaymentRelatedtoSettlementofDebtandBuyoutofRoyaltyObligations`	-	USD	2 Qtrs
Payments made on royalty obligations	`PaymentRelatedtoSettlementofDebtandBuyoutofRoyaltyObligations`	$151.00K	USD	2 Qtrs
Payments made on capital lease obligations	`RepaymentsOfLongTermCapitalLeaseObligations`	$62.00K	USD	2 Qtrs
Payments made on capital lease obligations	`RepaymentsOfLongTermCapitalLeaseObligations`	$399.00K	USD	2 Qtrs
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$5.53M	USD	2 Qtrs
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$1.73M	USD	2 Qtrs
Proceeds from issuance of common stock upon the exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	2 Qtrs
Proceeds from issuance of common stock upon the exercise of warrants	`ProceedsFromWarrantExercises`	$6.00K	USD	2 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$172.00K	USD	2 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	2 Qtrs
Proceeds from issuances of common stock under employee stock purchase plan	`ProceedsFromStockPlans`	$1.93M	USD	2 Qtrs
Proceeds from issuances of common stock under employee stock purchase plan	`ProceedsFromStockPlans`	-	USD	2 Qtrs
Proceeds from follow-on offering, net of underwriting discounts and commissions	`ProceedsFromIssuanceOrSaleOfEquity`	$350.43M	USD	2 Qtrs
Proceeds from follow-on offering, net of underwriting discounts and commissions	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	2 Qtrs
Payment of offering costs related to initial public offering and follow-on offering	`PaymentsOfStockIssuanceCosts`	$168.00K	USD	2 Qtrs
Payment of offering costs related to initial public offering and follow-on offering	`PaymentsOfStockIssuanceCosts`	$326.00K	USD	2 Qtrs
Net proceeds from issuance of equity interests in redeemable noncontrolling interest	`ProceedsFromMinorityShareholders`	$41.00M	USD	2 Qtrs
Net proceeds from issuance of equity interests in redeemable noncontrolling interest	`ProceedsFromMinorityShareholders`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$42.00M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$357.36M	USD	2 Qtrs
Net effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	2 Qtrs
Net effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$90.00K	USD	2 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$34.11M	USD	2 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$38.60M	USD	2 Qtrs
Cash, cash equivalents and restricted cash - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$111.19M	USD	Point-in-time
Cash, cash equivalents and restricted cash - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$72.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$140.54M	USD	Point-in-time
Cash, cash equivalents and restricted cash - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$174.65M	USD	Point-in-time
Cash, cash equivalents and restricted cash - End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$111.19M	USD	Point-in-time
Cash, cash equivalents and restricted cash - End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$72.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash - End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$140.54M	USD	Point-in-time
Cash, cash equivalents and restricted cash - End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$174.65M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$580.00K	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$51.00K	USD	2 Qtrs
Purchases of property and equipment included in accounts payable and accrued expenses	`IncreaseDecreaseInCapitalExpendituresIncurredButNotYetPaid`	$3.87M	USD	2 Qtrs
Purchases of property and equipment included in accounts payable and accrued expenses	`IncreaseDecreaseInCapitalExpendituresIncurredButNotYetPaid`	$4.99M	USD	2 Qtrs
Deferred offering costs included in accounts payable and accrued expenses	`OfferingCostsIncurredbutNotyetPaid`	$1.79M	USD	2 Qtrs
Deferred offering costs included in accounts payable and accrued expenses	`OfferingCostsIncurredbutNotyetPaid`	$485.00K	USD	2 Qtrs
Initial fair value of contingent consideration at acquisition date	`BusinessCombinationContingentConsiderationLiability`	-	USD	Point-in-time
Initial fair value of contingent consideration at acquisition date	`BusinessCombinationContingentConsiderationLiability`	$1.14M	USD	Point-in-time

Stockholders Equity 44 line items

Line Item	Tag	Value	Unit	Period
Stock offering costs	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$723.00K	USD	1 Quarter
Fair value adjustment of redeemable noncontrolling interest	`ReclassificationsOfTemporaryToPermanentEquity`	$-300.00K	USD	1 Quarter
Fair value adjustment of redeemable noncontrolling interest	`ReclassificationsOfTemporaryToPermanentEquity`	$-4.70M	USD	1 Quarter
Beginning balance	`StockholdersEquity`	$483.15M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$296.85M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$308.61M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$468.13M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$276.78M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$815.47M	USD	Point-in-time
Issuance of common stock upon follow-on offering, net of offering costs of $723	`StockIssuedDuringPeriodValueNewIssues`	$349.71M	USD	1 Quarter
Issuance of common stock upon exercise of stock options, shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	1.68M	shares	2 Qtrs
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.10M	USD	1 Quarter
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$538.00K	USD	1 Quarter
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$4.99M	USD	1 Quarter
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$424.00K	USD	1 Quarter
Vesting of restricted stock units (in shares)	`StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures`	1,106.00	shares	1 Quarter
Vesting of common stock exercised early	`StockIssuedDuringPeriodValueStockOptionsExercisedEarly`	$13.00K	USD	1 Quarter
Vesting of common stock exercised early	`StockIssuedDuringPeriodValueStockOptionsExercisedEarly`	$56.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.21M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.18M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.28M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.18M	USD	1 Quarter
Common stock issued under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$1.93M	USD	1 Quarter
Issuance of common stock upon exercise of warrants	`StockIssuedDuringPeriodValueExerciseofWarrants`	$4.00K	USD	1 Quarter
Issuance of common stock upon exercise of warrants	`StockIssuedDuringPeriodValueExerciseofWarrants`	$2.00K	USD	1 Quarter
Repurchase of common stock	`StockRepurchasedDuringPeriodValue`	$172.00K	USD	1 Quarter
Other comprehensive gain (loss), net of tax impact	`OtherComprehensiveIncomeLossNetOfTax`	$1.01M	USD	1 Quarter
Other comprehensive gain (loss), net of tax impact	`OtherComprehensiveIncomeLossNetOfTax`	$-298.00K	USD	1 Quarter
Other comprehensive gain (loss), net of tax impact	`OtherComprehensiveIncomeLossNetOfTax`	$416.00K	USD	1 Quarter
Other comprehensive gain (loss), net of tax impact	`OtherComprehensiveIncomeLossNetOfTax`	$138.00K	USD	1 Quarter
Other comprehensive gain (loss), net of tax impact	`OtherComprehensiveIncomeLossNetOfTax`	$-160.00K	USD	2 Qtrs
Other comprehensive gain (loss), net of tax impact	`OtherComprehensiveIncomeLossNetOfTax`	$1.43M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-11.30M	USD	1 Quarter
Net loss	`ProfitLoss`	$-13.84M	USD	1 Quarter
Net loss	`ProfitLoss`	$-35.48M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-21.35M	USD	1 Quarter
Net loss	`ProfitLoss`	$-21.64M	USD	1 Quarter
Net loss	`ProfitLoss`	$-32.65M	USD	2 Qtrs
Ending balance	`StockholdersEquity`	$483.15M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$296.85M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$308.61M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$468.13M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$276.78M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$815.47M	USD	Point-in-time

Comprehensive Income 32 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-11.30M	USD	1 Quarter
Net loss	`ProfitLoss`	$-13.84M	USD	1 Quarter
Net loss	`ProfitLoss`	$-35.48M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-21.35M	USD	1 Quarter
Net loss	`ProfitLoss`	$-21.64M	USD	1 Quarter
Net loss	`ProfitLoss`	$-32.65M	USD	2 Qtrs
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$138.00K	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$852.00K	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.34M	USD	2 Qtrs
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-160.00K	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	-	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	-	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$159.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$90.00K	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$1.01M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-298.00K	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$416.00K	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$138.00K	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-160.00K	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$1.43M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-31.22M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-35.64M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-21.50M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-10.29M	USD	1 Quarter
Comprehensive loss attributable to redeemable noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$5.00M	USD	2 Qtrs
Comprehensive loss attributable to redeemable noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Comprehensive loss attributable to redeemable noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$300.00K	USD	1 Quarter
Comprehensive loss attributable to redeemable noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	-	USD	2 Qtrs
Comprehensive loss attributable to Guardant Health, Inc.	`ComprehensiveIncomeNetOfTax`	$-21.50M	USD	1 Quarter
Comprehensive loss attributable to Guardant Health, Inc.	`ComprehensiveIncomeNetOfTax`	$-10.59M	USD	1 Quarter
Comprehensive loss attributable to Guardant Health, Inc.	`ComprehensiveIncomeNetOfTax`	$-35.64M	USD	2 Qtrs
Comprehensive loss attributable to Guardant Health, Inc.	`ComprehensiveIncomeNetOfTax`	$-36.22M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.